A Phase 2 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003054/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study will investigate how well adalimumab works in people with hidradenitis suppurativa (HS) in the short and long term.
提供机构：
Vivli
创建时间：
2018-10-27
